News25/Ratings11
Price$0.90-0.85 (-48.33%)
2026-07-012026-10-02
News · 26 weeks35+100%
2026-04-262026-10-18
Mix2590d
- SEC Filings11(44%)
- Other9(36%)
- Insider4(16%)
- Earnings1(4%)
Latest news
25 items- PRWaldencast plc Files Form 15 to Deregister its Securities and Suspend its SEC Reporting Obligations under the Exchange ActThe Company has filed a Form 15 (Certification and Notice of Termination of Registration) with the SEC on October 15, 2026 to terminate registration of its Class A Ordinary Shares and Warrants under Section 12(g) and suspend reporting obligations under Section 15(d) LONDON, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Waldencast plc ("Waldencast" or the "Company") today announced that it has filed a Form 15 (Certification and Notice of Termination of Registration) with the Securities and Exchange Commission (the "SEC") to terminate the registration of its Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares"), and its redeemable warrants, each whole warrant exercisable
- SECSEC Form 6-K filed by Waldencast plc6-K - Waldencast plc (0001840199) (Filer)
- SECSEC Form 15-12G filed by Waldencast plc15-12G - Waldencast plc (0001840199) (Filer)
- SECSEC Form S-8 POS filed by Waldencast plcS-8 POS - Waldencast plc (0001840199) (Filer)
- SECSEC Form EFFECT filed by Waldencast plcEFFECT - Waldencast plc (0001840199) (Filer)
- SECSEC Form EFFECT filed by Waldencast plcEFFECT - Waldencast plc (0001840199) (Filer)
- SECSEC Form EFFECT filed by Waldencast plcEFFECT - Waldencast plc (0001840199) (Filer)
- SECSEC Form POS AM filed by Waldencast plcPOS AM - Waldencast plc (0001840199) (Filer)
- SECSEC Form POS AM filed by Waldencast plcPOS AM - Waldencast plc (0001840199) (Filer)
- SECSEC Form POS AM filed by Waldencast plcPOS AM - Waldencast plc (0001840199) (Filer)
- PRWaldencast plc Announces First Half 2026 Financial ResultsNEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), the parent company of Milk Makeup, the clean prestige beauty brand born from the creative community of Milk Studios in downtown New York City, today announced operating results for the six months ended June 30, 2026 ("H1 2026") and provided a business update. On July 30, 2026, the Company completed the sale of the Obagi Medical business to Bridgepoint. The Company determined that this disposal met the criteria for classification as held for sale and represented a strategic shift that will have a major effect on the Company’s operations and financial results. Accordingly, the assets a
- SECSEC Form 6-K filed by Waldencast plc6-K - Waldencast plc (0001840199) (Filer)
- SECSEC Form 6-K filed by Waldencast plc6-K - Waldencast plc (0001840199) (Filer)
- PRWaldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange ActThe Company has filed a Form 25 (Notification of Removal from Listing) with the SEC on September 24, 2026 to remove its Class A Ordinary Shares and Warrants from listing on Nasdaq and to deregister those securities under the Exchange ActDelisting expected to become effective on or about October 4, 2026, with the last day of trading on Nasdaq expected to be on or about October 2, 2026 LONDON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company") today announced that it has filed a Form 25 (Notification of Removal from Listing) with the Securities and Exchange Commission (the "SEC") to remove its Class A ordinary shares, par value $0.0001 per share
- SECSEC Form 25 filed by Waldencast plc25 - Waldencast plc (0001840199) (Filer)
- PRWaldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange ActBoard to recommend that shareholders approve renaming the Company Milk Makeup plc The Company’s Board of Directors has approved the voluntary delisting of the Company’s Class A Ordinary Shares and Warrants from Nasdaq and the deregistration of those securities under the Exchange Act.Company expects to file a Form 25 with the SEC on or about September 24, 2026; delisting expected to become effective on or about October 4, 2026, with the last day of trading on Nasdaq expected to be October 2, 2026.Following completion of the sale of Obagi Medical, Waldencast is a single-brand company; shareholders will be asked at an Extraordinary General Meeting to approve renaming the Company Milk Makeup pl
- SECSEC Form 6-K filed by Waldencast plc6-K - Waldencast plc (0001840199) (Filer)
- INSIDERDirector Souza Cristiano bought $505,649 worth of Class A Ordinary Shares (335,000 units at $1.51) (SEC Form 4)4 - Waldencast plc (0001840199) (Issuer)
- INSIDERSEC Form 4 filed by Chief Executive Officer Brousset Michel4 - Waldencast plc (0001840199) (Issuer)
- INSIDERSEC Form 4 filed by Chief Growth Officer Sebti Hind4 - Waldencast plc (0001840199) (Issuer)
- INSIDERChief Financial Officer Manfredi Manuel converted options into 79,289 units of Class A Ordinary Shares, increasing direct ownership by 200% to 118,933 units (SEC Form 4)4 - Waldencast plc (0001840199) (Issuer)
- SECSEC Form 6-K filed by Waldencast plc6-K - Waldencast plc (0001840199) (Filer)
- SECSEC Form 6-K filed by Waldencast plc6-K - Waldencast plc (0001840199) (Filer)
- SECSEC Form 6-K filed by Waldencast plc6-K - Waldencast plc (0001840199) (Filer)
- PRWaldencast Announces Completion of the Sale of Obagi Medical to BridgepointLONDON, July 30, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or "the Company") today announced that it completed the previously announced sale of its Obagi Medical dermatological skincare and aesthetics business ("Obagi Medical") to Bridgepoint, one of the world's leading mid-market investors, in a transaction valued at up to $460 million (subject to negotiated deductions and customary adjustments based on closing cash, closing indebtedness, net working capital and transaction expenses), marking a significant step in Waldencast’s strategy to strengthen its balance sheet and focus on accelerating the global growth of Milk Makeup. As previously announced, in conjunct
WALD FAQ
7 questionsWhat does Waldencast plc do?
Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.Where does WALD stock trade?
Waldencast plc (WALD) is listed on NASDAQ.What sector and industry is WALD in?
Waldencast plc operates in the Consumer Discretionary sector, Package Goods/Cosmetics industry.When did Waldencast plc go public?
Waldencast plc (WALD) completed its IPO in 2021.What are analysts saying about WALD?
Waldencast plc has had 8 recent analyst actions on file. The most recent action was from Jefferies: Buy with a $200.00 price target on 2026-01-14.What companies are similar to WALD?
Notable peers in the same industry include PG (Procter & Gamble Company), UL (Unilever PLC), ECL (Ecolab Inc.), CL (Colgate-Palmolive Company), HLN (Haleon plc). Compare WALD side-by-side with any of them on Quantisnow.How can I track WALD on Quantisnow?
Quantisnow aggregates Waldencast plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow WALD to receive live email and push alerts on every new disclosure.